{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:13:01Z","timestamp":1759191181680,"version":"3.44.0"},"posted":{"date-parts":[[2024,7,15]]},"group-title":"In Review","reference-count":46,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,6,12]]},"abstract":"<title>Abstract<\/title>\n        <p>Background\n Aberrant activation of mTORC1 is clearly defined in TSC, causing uncontrolled cell growth. While mTORC1 inhibitors show efficacy to stabilise tumour growth in TSC, they are not fully curative. Disease facets of TSC that are not restored with mTOR inhibitors might involve NF-\u03baB. The study aimed to characterise NF-\u03baB in the context of TSC.\nResults\n Enrichment of NF-\u03baB-regulated genes was observed in TSC patient tumours, SEN\/SEGAs, cortical tubers and a TSC tumour-derived cell line (621\u2009\u2212\u2009101). Highlighting an inflammatory component of TSC, TSC cell models showed an elevated level of NF-\u03baB and STAT3 activation. Herein, we report a dysregulated inflammatory phenotype of <italic>TSC2<\/italic>-deficient cells where NF-\u03baB promotes autocrine signalling involving IL-6. Of importance, mTORC1 inhibition does not block this inflammatory signal to promote STAT3, while NF-\u03baB inhibition was much more effective. Combined mTORC1 and NF-\u03baB inhibition was potent at preventing anchorage-independent growth of <italic>TSC2<\/italic>-deficient cells, and unlike mTORC1 inhibition alone was sufficient to prevent colony regrowth after cessation of treatment.\nConclusion\n This study reveals autocrine signalling crosstalk between NF-\u03baB and STAT3 in TSC cell models. Furthermore, the data presented indicate that NF-\u03baB pathway inhibitors could be a viable adjunct therapy with the current mTOR inhibitors to treat TSC.<\/p>","DOI":"10.21203\/rs.3.rs-4569999\/v1","type":"posted-content","created":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T15:55:52Z","timestamp":1721058952000},"source":"Crossref","is-referenced-by-count":0,"title":["Loss of Tuberous Sclerosis Complex 2 confers inflammation via dysregulation of Nuclear factor kappa-light-chain-enhancer of activated B cells"],"prefix":"10.21203","author":[{"given":"Darius K.","family":"McPhail","sequence":"first","affiliation":[{"name":"Cardiff University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad A.M.","family":"Alzahrani","sequence":"additional","affiliation":[{"name":"Cardiff University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie R.","family":"Martin","sequence":"additional","affiliation":[{"name":"Michigan State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian L.","family":"Calver","sequence":"additional","affiliation":[{"name":"Cardiff University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adrian J.","family":"Harwood","sequence":"additional","affiliation":[{"name":"Cardiff University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey P.","family":"MacKeigan","sequence":"additional","affiliation":[{"name":"Michigan State University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David M.","family":"Davies","sequence":"additional","affiliation":[{"name":"South West Wales Cancer Centre, Singleton Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew R.","family":"Tee","sequence":"additional","affiliation":[{"name":"Cardiff University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","first-page":"91","volume-title":"Advances in Genetics","author":"McEneaney LJ","year":"2019","unstructured":"McEneaney LJ, Tee AR. Finding a cure for tuberous sclerosis complex: From genetics through to targeted drug therapies. Advances in Genetics. Academic Press Inc.; 2019. pp. 91\u2013118. 10.1016\/bs.adgen.2018.11.003."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s41687-018-0055-4","article-title":"Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey","volume":"2","author":"Rentz AM","year":"2018","unstructured":"Rentz AM, Skalicky AM, Liu Z, Dunn DW, Frost MD, Nakagawa JA, et al. Burden of renal angiomyolipomas associated with tuberous sclerosis complex: results of a patient and caregiver survey. J Patient Rep Outcomes. 2018;2. 10.1186\/s41687-018-0055-4.","journal-title":"J Patient Rep Outcomes"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1515\/revneuro-2017-0027","article-title":"The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: A review","volume":"29","author":"Chan DL","year":"2018","unstructured":"Chan DL, Calder T, Lawson JA, Mowat D, Kennedy SE. The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: A review. Rev Neurosci. 2018;29:295\u2013301. 10.1515\/revneuro-2017-0027.","journal-title":"Rev Neurosci"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157396","article-title":"Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex","volume":"11","author":"M\u00fchlebner A","year":"2016","unstructured":"M\u00fchlebner A, Van Scheppingen J, Hulshof HM, Scholl T, Iyer AM, Anink JJ, et al. Novel Histopathological Patterns in Cortical Tubers of Epilepsy Surgery Patients with Tuberous Sclerosis Complex. PLoS ONE. 2016;11. 10.1371\/journal.pone.0157396.","journal-title":"PLoS ONE"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.yebeh.2016.04.026","article-title":"White matter disruption is associated with persistent seizures in tuberous sclerosis complex","volume":"60","author":"Moavero R","year":"2016","unstructured":"Moavero R, Napolitano A, Cusmai R, Vigevano F, Fig\u00e0-Talamanca L, Calbi G, et al. White matter disruption is associated with persistent seizures in tuberous sclerosis complex. Epilepsy Behav. 2016;60:63\u20137. 10.1016\/j.yebeh.2016.04.026.","journal-title":"Epilepsy Behav"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10235495","article-title":"Risk Factors Associated with Refractory Epilepsy in Patients with Tuberous Sclerosis Complex: A Systematic Review","volume":"10","author":"Miszewska D","year":"2021","unstructured":"Miszewska D, Sugalska M, J\u00f3\u017awiak S. Risk Factors Associated with Refractory Epilepsy in Patients with Tuberous Sclerosis Complex: A Systematic Review. J Clin Med. 2021;10. 10.3390\/jcm10235495.","journal-title":"J Clin Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.35","article-title":"Tuberous sclerosis complex","volume":"2","author":"Henske EP","year":"2016","unstructured":"Henske EP, J\u00f3zwiak S, Kingswood JC, Sampson JR, Thiele EA. Tuberous sclerosis complex. Nat Rev Dis Primers. 2016;2. 10.1038\/nrdp.2016.35.","journal-title":"Nat Rev Dis Primers"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1016\/s0960-9822(03)00506-2","article-title":"Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb","volume":"13","author":"Tee AR","year":"2003","unstructured":"Tee AR, Manning BD, Roux PP, Cantley LC, Blenis J. Tuberous sclerosis complex gene products, Tuberin and Hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr Biol. 2003;13:1259\u201368. 10.1016\/s0960-9822(03)00506-2.","journal-title":"Curr Biol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.seizure.2021.10.011","article-title":"Long-term treatment with everolimus in TSC-associated therapy-resistant epilepsies","volume":"93","author":"Wiegand G","year":"2021","unstructured":"Wiegand G, May TW, Lehmann I, Stephani U, Kadish NE. Long-term treatment with everolimus in TSC-associated therapy-resistant epilepsies. Seizure. 2021;93:111\u20139. 10.1016\/j.seizure.2021.10.011.","journal-title":"Seizure"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/nejmoa063564","article-title":"Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis","volume":"358","author":"Bissler JJ","year":"2008","unstructured":"Bissler JJ, McCormack FX, Young LR, Elwing JM, Chuck G, Leonard JM, et al. Sirolimus for Angiomyolipoma in Tuberous Sclerosis Complex or Lymphangioleiomyomatosis. N Engl J Med. 2008;358:140. 10.1056\/nejmoa063564.","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s13238-013-2084-3","article-title":"NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer","volume":"4","author":"Fan Y","year":"2013","unstructured":"Fan Y, Mao R, Yang J. NF-\u03baB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 2013;4:176. 10.1007\/s13238-013-2084-3.","journal-title":"Protein Cell"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.2147\/ott.S161109","article-title":"Role of the NF\u03baB-signaling pathway in cancer","volume":"11","author":"Xia L","year":"2018","unstructured":"Xia L, Tan S, Zhou Y, Lin J, Wang H, Oyang L, et al. Role of the NF\u03baB-signaling pathway in cancer. Onco Targets Ther. 2018;11:2063. 10.2147\/ott.S161109.","journal-title":"Onco Targets Ther"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22020603","article-title":"The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy","volume":"22","author":"Tolomeo M","year":"2021","unstructured":"Tolomeo M, Cascio A. The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy. Int J Mol Sci. 2021;22:1\u201325. 10.3390\/ijms22020603.","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cytogfr.2016.05.001","volume-title":"STAT3 signaling in immunity. Vol. 31, Cytokine and Growth Factor Reviews","author":"Hillmer EJ","year":"2016","unstructured":"Hillmer EJ, Zhang H, Li HS, Watowich SS. STAT3 signaling in immunity. Vol. 31, Cytokine and Growth Factor Reviews. Elsevier Ltd; 2016. pp. 1\u201315. 10.1016\/j.cytogfr.2016.05.001."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/intimm\/dxz061","article-title":"Phospho-Ser727 triggers a multistep inactivation of STAT3 by rapid dissociation of pY705\u2013SH2 through C-terminal tail modulation","volume":"32","author":"Yang J","year":"2020","unstructured":"Yang J, Kunimoto H, Katayama B, Zhao H, Shiromizu T, Wang L, et al. Phospho-Ser727 triggers a multistep inactivation of STAT3 by rapid dissociation of pY705\u2013SH2 through C-terminal tail modulation. Int Immunol. 2020;32:73\u201388. 10.1093\/intimm\/dxz061.","journal-title":"Int Immunol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0092-8674(95)90311-9","article-title":"Maximal activation of transcription by stat1 and stat3 requires both tyrosine and serine phosphorylation","volume":"82","author":"Wen Z","year":"1995","unstructured":"Wen Z, Zhong Z, Darnell JE. Maximal activation of transcription by stat1 and stat3 requires both tyrosine and serine phosphorylation. Cell. 1995;82:241\u201350. 10.1016\/0092-8674(95)90311-9.","journal-title":"Cell"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"6195","DOI":"10.3390\/cancers14246195","article-title":"Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells","volume":"14","author":"Champion JD","year":"2022","unstructured":"Champion JD, Dodd KM, Lam HC, Alzahrani MAM, Seifan S, Rad E, et al. Drug Inhibition of Redox Factor-1 Restores Hypoxia-Driven Changes in Tuberous Sclerosis Complex 2 Deficient Cells. Cancers. 2022;14:6195. 10.3390\/cancers14246195.","journal-title":"Cancers"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1158\/1541-7786.mrc-15-0213","article-title":"Differential IKK\/NF-\u03baB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null prostate cancer and tuberous sclerosis complex tumor cells","volume":"13","author":"Gao Y","year":"2015","unstructured":"Gao Y, Gartenhaus RB, Lapidus RG, Hussain A, Zhang Y, Wang X, et al. Differential IKK\/NF-\u03baB Activity Is Mediated by TSC2 through mTORC1 in PTEN-Null prostate cancer and tuberous sclerosis complex tumor cells. Mol Cancer Res. 2015;13:1602\u201314. 10.1158\/1541-7786.mrc-15-0213.","journal-title":"Mol Cancer Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.immuni.2008.08.012","article-title":"The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response","volume":"29","author":"Weichhart T","year":"2008","unstructured":"Weichhart T, Costantino G, Poglitsch M, Rosner M, Zeyda M, Stuhlmeier KM, et al. The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response. Immunity. 2008;29:565\u201377. 10.1016\/j.immuni.2008.08.012.","journal-title":"Immunity"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1152\/ajplung.00204.2003","article-title":"Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways","volume":"286","author":"Yu J","year":"2004","unstructured":"Yu J, Astrinidis A, Howard S, Henske EP. Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways. Am J Physiol Lung Cell Mol Physiol. 2004;286:694\u2013700. 10.1152\/ajplung.00204.2003.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.molcel.2008.04.027","article-title":"mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation","volume":"30","author":"Hong F","year":"2008","unstructured":"Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace R, Slingerland JM. mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell. 2008;30:701\u201311. 10.1016\/j.molcel.2008.04.027.","journal-title":"Mol Cell"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1172\/jci17222","article-title":"Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR","volume":"112","author":"Zhang H","year":"2003","unstructured":"Zhang H, Cicchetti G, Onda H, Koon HB, Asrican K, Bajraszewski N, et al. Loss of Tsc1\/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR. J Clin Invest. 2003;112:1223\u201333. 10.1172\/jci17222.","journal-title":"J Clin Invest"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"8470","DOI":"10.1038\/sj.onc.1205962","article-title":"Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration","volume":"21","author":"Astrinidis A","year":"2002","unstructured":"Astrinidis A, Cash TP, Hunter DS, Walker CL, Chernoff J, Henske EP. Tuberin, the tuberous sclerosis complex 2 tumor suppressor gene product, regulates Rho activation, cell adhesion and migration. Oncogene. 2002;21:8470\u20136. 10.1038\/sj.onc.1205962.","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"5913","DOI":"10.1038\/s41388-018-0381-2","article-title":"Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir\u2009\u2013\u2009bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death","volume":"37","author":"Johnson CE","year":"2018","unstructured":"Johnson CE, Dunlop EA, Seifan S, McCann HD, Hay T, Parfitt GJ, et al. Loss of tuberous sclerosis complex 2 sensitizes tumors to nelfinavir\u2009\u2013\u2009bortezomib therapy to intensify endoplasmic reticulum stress-induced cell death. Oncogene. 2018;37:5913\u201325. 10.1038\/s41388-018-0381-2.","journal-title":"Oncogene"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love MI","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:1\u201321. 10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"15816","DOI":"10.1038\/ncomms15816","article-title":"The genomic landscape of tuberous sclerosis complex","volume":"8","author":"Martin KR","year":"2017","unstructured":"Martin KR, Zhou W, Bowman MJ, Shih J, Au KS, Dittenhafer-Reed KE, et al. The genomic landscape of tuberous sclerosis complex. Nat Commun. 2017;8:15816. 10.1038\/ncomms15816.","journal-title":"Nat Commun"},{"author":"Gilmore T","key":"ref27","unstructured":"Gilmore T. NF-kB Target Genes \u00bb NF-kB Transcription Factors. Boston University. https:\/\/www.bu.edu\/nf-kb\/gene-resources\/target-genes\/ Accessed 22 Nov 2022."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1124\/mol.109.057042","article-title":"Signal Transducer and Activator of Transcription 3 Is Required for Abnormal Proliferation and Survival of TSC2-Deficient Cells: Relevance to Pulmonary Lymphangioleiomyomatosis","volume":"76","author":"Goncharova EA","year":"2009","unstructured":"Goncharova EA, Goncharov DA, Damera G, Tliba O, Amrani Y, Panettieri RA, et al. Signal Transducer and Activator of Transcription 3 Is Required for Abnormal Proliferation and Survival of TSC2-Deficient Cells: Relevance to Pulmonary Lymphangioleiomyomatosis. Mol Pharmacol. 2009;76:766. 10.1124\/mol.109.057042.","journal-title":"Mol Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e2101268118","DOI":"10.1073\/pnas.2101268118","article-title":"Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells","volume":"118","author":"Wang J","year":"2021","unstructured":"Wang J, Filippakis H, Hougard T, Du H, Ye C, Liu HJ, et al. Interleukin-6 mediates PSAT1 expression and serine metabolism in TSC2-deficient cells. Proc Natl Acad Sci U S A. 2021;118:e2101268118. 10.1073\/pnas.2101268118.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/sj.bjc.6605530","article-title":"TNF-alpha\/NF-kappaB\/Snail pathway in cancer cell migration and invasion","volume":"102","author":"Wu Y","year":"2010","unstructured":"Wu Y, Zhou BP. TNF-alpha\/NF-kappaB\/Snail pathway in cancer cell migration and invasion. Br J Cancer. 2010;102:639\u201344. 10.1038\/sj.bjc.6605530.","journal-title":"Br J Cancer"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/20734735.0007-2020","article-title":"Lymphangioleiomyomatosis: a clinical review","volume":"16","author":"O\u2019mahony AM","year":"2020","unstructured":"33, O\u2019mahony AM, Lynn E, Murphy DJ, Fabre A, McCarthy C. Lymphangioleiomyomatosis: a clinical review. Breathe. 2020;16:1\u201311. 10.1183\/20734735.0007-2020.","journal-title":"Breathe"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider CA","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135. 10.1038\/nmeth.2089.","journal-title":"Nat Methods"},{"key":"ref33","unstructured":"Immune Checkpoint Proteins - ACROBiosystems. https:\/\/www.acrobiosystems.com\/A974-Immune-Checkpoint-Proteins.html?gad_source=1&gclid=EAIaIQobChMIoZry6OrBhgMVM5FQBh29qw5nEAAYASAAEgLPzPD_BwE Accessed 04 Jun 2024."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"100811","DOI":"10.1016\/j.tranon.2020.100811","article-title":"Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer?","volume":"13","author":"Solinas C","year":"2020","unstructured":"Solinas C, Aiello M, Rozali E, Lambertini M, Willard-Gallo K, Migliori E. Programmed cell death-ligand 2: A neglected but important target in the immune response to cancer? Transl Oncol. 2020;13:100811. 10.1016\/j.tranon.2020.100811.","journal-title":"Transl Oncol"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/mp.2016.90","article-title":"Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review","volume":"21","author":"Tr\u00e9panier MO","year":"2016","unstructured":"Tr\u00e9panier MO, Hopperton KE, Mizrahi R, Mechawar N, Bazinet RP. Postmortem evidence of cerebral inflammation in schizophrenia: a systematic review. Mol Psychiatry. 2016;21:1009\u201326. 10.1038\/mp.2016.90.","journal-title":"Mol Psychiatry"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1038\/mp.2015.168","article-title":"Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression","volume":"21","author":"Felger JC","year":"2016","unstructured":"Felger JC, Li Z, Haroon E, Woolwine BJ, Jung MY, Hu X, et al. Inflammation is associated with decreased functional connectivity within corticostriatal reward circuitry in depression. Mol Psychiatry. 2016;21:1358\u201365. 10.1038\/mp.2015.168.","journal-title":"Mol Psychiatry"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbi.2019.04.037","article-title":"The influence of neuroinflammation in Autism Spectrum Disorder","volume":"79","author":"Matta SM","year":"2019","unstructured":"Matta SM, Hill-Yardin EL, Crack PJ. The influence of neuroinflammation in Autism Spectrum Disorder. Brain Behav Immun. 2019;79:75\u201390. 10.1016\/j.bbi.2019.04.037.","journal-title":"Brain Behav Immun"},{"issue":"Suppl 3","key":"ref38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/j.1528-1167.2011.03033.x","article-title":"Inflammation in epilepsy: clinical observations","volume":"52","author":"Aronica E","year":"2011","unstructured":"Aronica E, Crino PB. Inflammation in epilepsy: clinical observations. Epilepsia. 2011;52(Suppl 3):26\u201332. 10.1111\/j.1528-1167.2011.03033.x.","journal-title":"Epilepsia"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1007\/s11064-011-0576-1","article-title":"Role of signal transducer and activator of transcription-3 in up-regulation of GFAP after epilepsy","volume":"36","author":"Xu Z","year":"2011","unstructured":"Xu Z, Xue T, Zhang Z, Wang X, Xu P, Zhang J, et al. Role of signal transducer and activator of transcription-3 in up-regulation of GFAP after epilepsy. Neurochem Res. 2011;36:2208\u201315. 10.1007\/s11064-011-0576-1.","journal-title":"Neurochem Res"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e22221","DOI":"10.1002\/syn.22221","article-title":"Role of Stat3 in NLRP3\/caspase-1-mediated hippocampal neuronal pyroptosis in epileptic mice","volume":"75","author":"Jiang Q","year":"2021","unstructured":"Jiang Q, Tang G, Zhong XM, Ding DR, Wang H, Li JN. Role of Stat3 in NLRP3\/caspase-1-mediated hippocampal neuronal pyroptosis in epileptic mice. Synapse. 2021;75:e22221. 10.1002\/syn.22221.","journal-title":"Synapse"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","article-title":"NF-\u03baB signaling in inflammation","volume":"2","author":"Liu T","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC. NF-\u03baB signaling in inflammation. Signal Transduct Target Ther. 2017;2:17023. 10.1038\/sigtrans.2017.23.","journal-title":"Signal Transduct Target Ther"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cytogfr.2009.11.005","article-title":"Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer","volume":"21","author":"Grivennikov SI","year":"2010","unstructured":"Grivennikov SI, Karin M. Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev. 2010;21:11\u20139. 10.1016\/j.cytogfr.2009.11.005.","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1586\/ern.10.21","article-title":"NF-kappaB and STAT3 signaling in glioma: targets for future therapies","volume":"10","author":"Atkinson GP","year":"2010","unstructured":"Atkinson GP, Nozell SE, Benveniste ET. NF-kappaB and STAT3 signaling in glioma: targets for future therapies. Expert Rev Neurother. 2010;10:575\u201386. 10.1586\/ern.10.21.","journal-title":"Expert Rev Neurother"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1101\/gad.1662308","article-title":"Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK","volume":"22","author":"Dan HC","year":"2008","unstructured":"Dan HC, Cooper MJ, Cogswell PC, Duncan JA, Ting JP, Baldwin AS. Akt-dependent regulation of NF-{kappa}B is controlled by mTOR and Raptor in association with IKK. Genes Dev. 2008;22:1490\u2013500. 10.1101\/gad.1662308.","journal-title":"Genes Dev"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1111\/cas.13065","article-title":"An IL-27\/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1\/2) on infiltrating macrophages in lymphoma","volume":"107","author":"Horlad H","year":"2016","unstructured":"Horlad H, Ma C, Yano H, Pan C, Ohnishi K, Fujiwara Y, et al. An IL-27\/Stat3 axis induces expression of programmed cell death 1 ligands (PD-L1\/2) on infiltrating macrophages in lymphoma. Cancer Sci. 2016;107:1696\u2013704. 10.1111\/cas.13065.","journal-title":"Cancer Sci"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1016\/j.jtho.2018.03.012","article-title":"Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non-Small Cell Lung Cancer","volume":"13","author":"Shibahara D","year":"2018","unstructured":"Shibahara D, Tanaka K, Iwama E, Kubo N, Ota K, Azuma K, et al. Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non-Small Cell Lung Cancer. J Thorac Oncol. 2018;13:926\u201337. 10.1016\/j.jtho.2018.03.012.","journal-title":"J Thorac Oncol"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4569999\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4569999\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:07:08Z","timestamp":1759162028000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-4569999\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,15]]},"references-count":46,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-4569999\/v1","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1186\/s12950-025-00464-8","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2024,7,15]]},"subtype":"preprint"}}